Viewpoints

Should Oncology Drug Trials Rely Less on Overall Survival?

Should Oncology Drug Trials Rely Less on Overall Survival?

Calls for wider adoption of surrogate survival measures as clinical trial endpoints should be considered cautiously; physicians should carefully consider—and communicate to patients—clinical trials' endpoints.

Novel Toxicity Examinations for Patients Treated With Targeted Therapies

Novel Toxicity Examinations for Patients Treated With Targeted Therapies

Instead of analyzing adverse events (AEs) in the traditional fashion, we ought to consider alternatives in this new era of personalized medicine.

Feature Articles

Melanoma Patients May Not Require Complete Lymph Node Dissection

Melanoma Patients May Not Require Complete Lymph Node Dissection

A phase 3 trial of patients with cutaneous melanoma found no difference in distant metastasis-free survival between those who underwent complete lymph node dissection and those who did not.

Skin Cancer Resources

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters